Company intelligence / Profile preview

FluoSphera

Plan-les-Ouates or Geneva, Geneva Canton, Switzerlandfluosphera.com ↗

Ownership: Private
Employees: ~3
Development stage: Other

Overview

FluoSphera has developed a patented in vitro multi-tissue microphysiological system that mimics human systemic responses. This platform enables high-resolution, multiplexed drug profiling before clinical trials, providing predictive data on efficacy, safety, tissue selectivity, and off-target effects. The company recently expanded into antibody-drug conjugate testing for oncology applications. No direct clinical results are reported as the company offers enabling technologies/services rather than proprietary therapeutics.

Therapeutic areas: OncologyOther
Modalities: Antibody-drug conjugates (ADCs)Small moleculesBiologics and bioconjugatesNanodrugs
Industry: Drug Discovery Services

Partnerships

Revvity

Beyond the preview

Go deeper on FluoSphera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FluoSphera.

Explore the full profile